Fragment-based discovery of JAK-2 inhibitors

被引：69

作者：

Antonysamy, Stephen ^{[1
]}

Hirst, Gavin ^{[1
]}

Park, Frances ^{[1
]}

Sprengeler, Paul ^{[1
]}

Stappenbeck, Frank ^{[1
]}

Steensma, Ruo ^{[1
]}

Wilson, Mark ^{[1
]}

Wong, Melissa ^{[1
]}

机构：

[1] SGX Pharmaceut Inc, Med Chem, San Diego, CA 92121 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 01期

关键词：

Fragment-based design; JAK-2; inhibitors; Structure-based design; Aminoindazole; Kinase inhibitors; MYELOPROLIFERATIVE DISORDERS; JAK/STAT PATHWAY; STATS;

D O I：

10.1016/j.bmcl.2008.08.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fragment-based hit identification coupled with crystallographically enabled structure-based drug design was used to design potent inhibitors of JAK-2. After two iterations from fragment 1, we were able to increase potency by greater than 500-fold to provide sulfonamide 13, a 78-nM JAK-2 inhibitor. (C) 2008 Published by Elsevier Ltd.

引用

页码：279 / 282

页数：4

共 50 条

[31] Identification of potent, selective JAK2 inhibitors using a fragment-based screening approach
Wallis, N. G.
Chessari, G.
Curry, J. E.
Hamlett, C.
Lewry, K. A.
Lyons, J.
Richardson, C. J.
Tisi, D.
Walker, D.
Woodhead, A. J.
EJC SUPPLEMENTS, 2008, 6 (12): : 180 - 180
[32] Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13
Agamennone, Mariangela
Belov, Dmitry S.
Laghezza, Antonio
Ivanov, Vladimir N.
Novoselov, Anton M.
Andreev, Ivan A.
Ratmanova, Nina K.
Altieri, Andrea
Tortorella, Paolo
Kurkin, Alexander V.
CHEMMEDCHEM, 2016, 11 (17) : 1892 - 1898
[33] Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
Demont, Emmanuel H.
Chung, Chun-wa
Furze, Rebecca C.
Grandi, Paola
Michon, Anne-Marie
Wellaway, Chris
Barrett, Nathalie
Bridges, Angela M.
Craggs, Peter D.
Diallo, Hawa
Dixon, David P.
Douault, Clement
Emmons, Amanda J.
Jones, Emma J.
Karamshi, Bhumika V.
Locke, Kelly
Mitchell, Darren J.
Mouzon, Bernadette H.
Prinjha, Rab K.
Roberts, Andy D.
Sheppard, Robert J.
Watson, Robert J.
Bamborough, Paul
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (14) : 5649 - 5673
[34] Fragment-based discovery of small molecule inhibitors of the HDGFRP2 PWWP domain
Wei, Xiaoli
Li, Shuju
Li, Zihuan
Wang, Lei
Fan, Weiwei
Ruan, Ke
Gao, Jia
FEBS LETTERS, 2024, 598 (20) : 2533 - 2543
[35] Fragment-Based and Structural Investigation for Discovery of JNK3 Inhibitors
Men Thi Hoai Duong
Ahn, Hee-Chul
PHARMACEUTICS, 2022, 14 (09)
[36] Fragment-Based Discovery of AF9 YEATS Domain Inhibitors
Liu, Yaqian
Jin, Ruoxing
Lu, Hui
Bian, Kangjie
Wang, Rui
Wang, Lei
Gao, Rui
Zhang, Jiahai
Wu, Jihui
Yao, Xuebiao
Liu, Xing
Liu, Dan
Wang, Xisheng
Zhang, Zhiyong
Ruan, Ke
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[37] Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors
Gibbs, Alan C.
Abad, Marta C.
Zhang, Xuqing
Tounge, Brett A.
Lewandowski, Francis A.
Struble, Geoffrey T.
Sun, Weimei
Sui, Zhihua
Kuo, Lawrence C.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 7979 - 7991
[38] Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
Chilingaryan, Zorik
Headey, Stephen J.
Lo, Allen T. Y.
Xu, Zhi-Qiang
Otting, Gottfried
Dixon, Nicholas E.
Scanlon, Martin J.
Oakley, Aaron J.
ANTIBIOTICS-BASEL, 2018, 7 (01): : 1 - 12
[39] Novel approach of fragment-based lead discovery applied to renin inhibitors
Tawada, Michiko
Suzuki, Shinkichi
Imaeda, Yasuhiro
Oki, Hideyuki
Snell, Gyorgy
Behnke, Craig A.
Kondo, Mitsuyo
Tarui, Naoki
Tanaka, Toshimasa
Kuroita, Takanobu
Tomimoto, Masaki
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) : 6066 - 6074
[40] Discovery of Mcl-1 inhibitors using fragment-based methods
Fesik, Stephen W.
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)

← 1 2 3 4 5 →